Sprinter Legend Balloon Catheter
NCT00961311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2011-10-26
Summary
Open label, single-arm trial to study the safety and effectiveness of the Sprinter Legend 1.25 mm angioplasty balloon.
Conditions
Interventions
- PROCEDURE
-
Percutaneous Coronary Intervention
Balloon angioplasty of a severely stenotic coronary lesion with the Sprinter Legend 1.25mm Balloon.
- DEVICE
-
Sprinter Legend 1.25mm Balloon Catheter
Balloon Angioplasty
Sponsors & Collaborators
-
Medtronic Vascular
lead INDUSTRY
Principal Investigators
-
David Kandzari, MD · Scripps Green Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- United States
Study Locations
More Related Trials
-
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893 ·Status: RECRUITING ·Phase: NA
-
Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment
NCT03899818 ·Status: COMPLETED ·Phase: NA
-
Drug-Coated Balloon in Combination With New Generation Drug-Eluting Stent for de Novo Diffuse Disease Treatment
NCT03939468 ·Status: UNKNOWN
-
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels
NCT06345209 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
NCT01396525 ·Status: COMPLETED ·Phase: PHASE3
-
Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients
NCT05937230 ·Status: ACTIVE_NOT_RECRUITING
-
Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions
NCT00233714 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cutting Balloon Predilation Prior to Abluminus Sirolimus-eluting Stent Implantation (CUT-DRESS).
NCT05801003 ·Status: RECRUITING ·Phase: NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NCT05908331 ·Status: RECRUITING ·Phase: NA
-
The PREVAIL Study
NCT03260517 ·Status: COMPLETED ·Phase: NA
-
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
NCT05033964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
NCT02419521 ·Status: COMPLETED ·Phase: NA
-
DCB for CAD With Type 2 Diabetes
NCT07009938 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis
NCT00961181 ·Status: COMPLETED ·Phase: NA
-
Rise Semi Compliant Balloon Study in Patient With CAD
NCT04796038 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort
NCT06492174 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison
NCT00279006 ·Status: UNKNOWN ·Phase: NA
-
The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial
NCT00217256 ·Status: COMPLETED ·Phase: NA
-
Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.
NCT00609947 ·Status: COMPLETED ·Phase: NA
-
Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease
NCT00192881 ·Status: UNKNOWN ·Phase: NA
-
The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
NCT00233805 ·Status: COMPLETED ·Phase: PHASE2
-
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
NCT06271590 ·Status: RECRUITING ·Phase: NA
-
SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)
NCT01171820 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention
NCT03049657 ·Status: COMPLETED ·Phase: NA
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA